Effects of Kudiezi Injection on Serum Inflammatory Biomarkers in Patients with Acute Cerebral Infarction.
Xuemei LiuXianglan JinBaoxin ChenXiaohan LiuXiao LiangXiaolei FangHongyun WuXiaoyu FuHong ZhengXiao DingNa DuanYun-Ling ZhangPublished in: Disease markers (2018)
Kudiezi injection could lead to early reduction of interleukin-6, interleukin-18, matrix metaloproteinase-9, neuron-specific enolase, and S100 calcium-binding protein B levels and increases of interleukin-10 levels in patients with acute ischemic stroke. This trial is registered with ClinicalTrials.gov NCT01636154.